Diabetes affects millions of Americans, and many don’t even realize they have it. Instead of relying on costly and ...
The San Diego-based company claims a number of firsts for its coin-sized Biolinq Shine device, including that it is so far ...
The Food and Drug Administration has granted de novo classification to a continuous glucose monitor made by Biolinq for ...
Tariffs and price hikes are putting access to medical devices at risk Every 10 days I insert a glucose sensor into my skin; every three days I change the site for my insulin pump. These US made ...
DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ ...
A team led by Huanyu “Larry” Cheng, the James L. Henderson, Jr Memorial Associate Professor of Engineering Science and ...
The Brighterside of News on MSN
Real-time glucose and heart monitoring in a smart wearable device
A new kind of wearable wristband could reshape how people with diabetes understand and manage their health. In addition to ...
Asianet Newsable on MSN
Breath Sensor Detects Diabetes in Minutes, Without Needles
Penn State researchers developed a portable breath sensor that detects diabetes and prediabetes in minutes by measuring ...
Dallara, president of Medtronic’s diabetes business, discussed the segment’s turnaround and why she sees a benefit in ...
Biolinq announced today that it received FDA de novo clearance for its lead product, the Biolinq Shine wearable biosensor.
In the U.S., one in five of the 37 million adults who has diabetes is not aware of it (according to the U.S. CDC – Centers for Disease Control & Prevention). Current methods of diagnosing diabetes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback